Tagged: CNS

CNS Development Makes a Comeback

Only yesterday, we were reading about the death of CNS drug development.  The reasons were simple: first, several Big Pharma companies were abandoning or cutting their CNS programs; and second, there seemed to be a consensus that odds were against translating CNS-related innovations in basic science into successful clinical programs. That was in December 2011…. Read more »